National Kidney and Transplant Institute, Philippines Report issue

Academic/Hospital Phase 1 Phase 4

Organization Overview

First Clinical Trial
2014
NCT04313868
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

National Kidney and Transplant Institute | National Kidney and Transplant Institute, Philippines

Active Ingredients

Drugs in Phase 4 Trials (1)

epoetin (Epogen) (1 trial)

Drugs in Phase 1 Trials (1)

gen2 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 1)

Carcinoma, Hepatocellular (Phase 1)

Kidney Diseases (Phase 4)

Renal Insufficiency, Chronic (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2